- Clinical research suggests berberine can lower LDL cholesterol, triglycerides, and total cholesterol, although the size of the change varies across studies.
-
Findings for HDL cholesterol are less consistent, with some reviews reporting a small increase and others finding no significant change.
-
The available trials are generally short-term, and some systematic reviews have rated the certainty of the evidence as low because of study limitations and inconsistent results.
-
Berberine may influence lipid metabolism through several biological pathways, but changes in cholesterol numbers do not establish that berberine prevents cardiovascular disease.
-
Berberine should not be used as a substitute for prescribed cholesterol treatment without medical guidance.
Cholesterol research on berberine has expanded beyond individual clinical trials, with systematic reviews and meta-analyses now bringing together findings from multiple studies. Researchers have examined different lipid markers, doses, treatment periods, and participant groups, which helps explain why results are not completely uniform.
This article looks specifically at what human research can tell us about berberine and cholesterol, how much lipid levels have changed in clinical studies, and why those findings can differ. It also looks at the biological mechanisms being investigated, without treating laboratory findings as proof of cardiovascular benefits.
What Does the Research Say About Berberine and Cholesterol?
Human research has examined berberine's effects on several blood lipid markers, with findings generally pointing toward lower LDL cholesterol, triglycerides, and total cholesterol. The evidence comes from individual clinical trials, systematic reviews, and broader reviews of meta-analyses, although the quality and design of the underlying studies vary.
LDL cholesterol
One early clinical report published in Expert Opinion on Investigational Drugs followed people with hypercholesterolaemia who took 500 mg of berberine hydrochloride twice daily for three months. Their LDL cholesterol fell from 3.2 to 2.4 mmol/L, while HDL cholesterol did not change. Triglycerides also fell, from 2.3 to 1.5 mmol/L.
A 2019 systematic review and meta-analysis in The American Journal of Chinese Medicine evaluated 11 randomised controlled trials involving 1,386 people with hyperlipidaemia. Compared with control treatment, berberine significantly reduced LDL cholesterol and total cholesterol and increased HDL cholesterol. The review also found that berberine did not differ significantly from simvastatin for LDL or HDL, although the authors cautioned that the number and quality of available trials were unsatisfactory.
Triglycerides
The same 2019 systematic review found a more specific result when berberine was compared directly with simvastatin: triglycerides were significantly lower with berberine, while the difference in LDL and HDL between the two groups was not statistically significant. When berberine was combined with simvastatin, the combination produced greater reductions in triglycerides and total cholesterol than simvastatin alone.
The older clinical study described above also reported a fall in triglycerides from 2.3 to 1.5 mmol/L after three months of berberine hydrochloride.
These findings give triglycerides a particularly useful place in the evidence discussion. Still, the statin comparison also shows why berberine should not be presented as interchangeable with established lipid-lowering medication.
Total cholesterol
The broader evidence base also points toward lower total cholesterol. A 2023 umbrella review in PharmaNutrition assessed 13 meta-analyses of randomised clinical trials and found that berberine supplementation was associated with reductions in LDL cholesterol, total cholesterol, and triglycerides, along with an increase in HDL cholesterol.
Because this was an umbrella review, it provides a higher-level view of the existing meta-analytic evidence.
HDL cholesterol
HDL is less consistent than the other lipid markers. The early clinical study found no change in HDL cholesterol after three months of berberine.
In contrast, the 2019 systematic review found that berberine increased HDL compared with control treatment, while the 2023 umbrella review also reported an overall increase in HDL across the meta-analyses it assessed.
That difference is one reason HDL should not be given the same level of confidence as the more consistent findings for LDL, triglycerides, and total cholesterol.
Overall, the evidence points toward a potential lipid-lowering effect from berberine, particularly for LDL cholesterol, triglycerides, and total cholesterol. However, the underlying trials differ in size, design, treatment duration, and quality, so the results should be interpreted as evidence of a potential effect, rather than a predictable change in an individual's cholesterol panel.
How Much Can Berberine Change Cholesterol?
The clinical studies do not produce one fixed number. Reported changes vary with the study population, starting lipid levels, dose, treatment duration, and study design.
|
Evidence |
Berberine exposure |
LDL cholesterol |
Total cholesterol |
Triglycerides |
HDL cholesterol |
|
Clinical study |
500 mg twice daily for 3 months |
3.2 → 2.4 mmol/L |
Not reported |
2.3 → 1.5 mmol/L |
No change reported |
|
2018 meta-analysis |
600–1,500 mg/day; studies lasted 1–24 months |
−0.38 mmol/L |
−0.47 mmol/L |
−0.28 mmol/L |
+0.08 mmol/L with berberine alone |
|
2023 meta-analysis |
Trials lasted 4–24 weeks |
−0.46 mmol/L |
−0.48 mmol/L |
−0.34 mmol/L |
+0.06 mmol/L |
Sources: 2005 clinical study · 2018 systematic review and meta-analysis · 2023 systematic review and meta-analysis
The individual clinical study shows why results can look larger than the averages from meta-analyses. In that study, LDL fell by about 25% and triglycerides by about 35% over three months.
The meta-analyses provide a broader picture because they combine results from multiple trials. Their average reductions were smaller, and the studies differed in dose, duration, participants, and methodology. The 2023 review included trials lasting only 4 to 24 weeks, so these figures mainly describe short-term changes.
So, if you're considering berberine for cholesterol, there isn't a reliable formula such as “X mg of berberine equals Y% lower LDL.” The clinical evidence supports potential changes in lipid levels, but the size of those changes varies from study to study and from person to person.
Why Might Berberine Affect Cholesterol?
Researchers have proposed several ways berberine may influence lipid metabolism, particularly in the liver. One area of interest is LDL receptor (LDLR) activity.
LDL receptors help remove LDL cholesterol from the bloodstream by allowing liver cells to take it up. Research suggests berberine can stabilise LDLR messenger RNA and may also influence pathways involved in LDLR degradation, potentially supporting cholesterol clearance.
Berberine may also affect how the liver makes and processes lipids. Research has examined its effects on targets involved in fatty acid and lipid production, including acetyl-CoA carboxylase (ACC), as well as pathways involved in cholesterol synthesis.
Another proposed pathway involves AMPK, an enzyme that acts as an energy sensor inside cells. When AMPK is activated, it can reduce activity in pathways involved in lipid production. Studies have linked berberine with AMPK-related changes in liver lipid metabolism, although much of this mechanistic evidence comes from laboratory and animal research rather than human clinical trials.
Why Do Berberine Studies Show Different Results?
Berberine studies do not all use the same people, formulations, doses, or treatment periods, so their findings can vary.
A few factors can change the results:
-
Starting cholesterol levels: Someone with elevated LDL or triglycerides may respond differently from someone whose levels are already within a healthy range.
-
Dose and formulation: Studies have used different amounts and forms of berberine, making direct comparisons difficult.
-
Treatment duration: A study lasting several weeks may capture a different response from one lasting several months.
-
Participant health: Diabetes, fatty liver disease, obesity, and other health conditions can affect lipid metabolism and may influence the response to supplementation.
-
Study design: Differences in sample size, comparison groups, diet, medications, and other interventions can also affect the results.
The National Center for Complementary and Integrative Health (NCCIH) notes that berberine research varies considerably in dosage, formulation, and participant characteristics.
For that reason, apparently conflicting studies do not necessarily mean that one study is correct and another is wrong. They may be examining berberine under different conditions.
What Does the Research Mean for People Considering Berberine?
The research suggests berberine can influence several lipid markers, particularly LDL cholesterol, triglycerides, and total cholesterol. That makes it an interesting option for adults looking to support healthy cholesterol levels, but it should not be treated as a replacement for prescribed cholesterol medication.
Cholesterol is also only one part of cardiovascular health. Blood pressure, smoking, diabetes, family history, existing cardiovascular disease, age, and current medications can all influence how cholesterol should be managed. If you take a statin or another cholesterol-lowering medication, speak with your healthcare professional before adding berberine to your routine.
Where Berberine+ fits in
Bioligent designed Berberine+ for adults who want broader metabolic support in one formula. Our formula combines highly bioavailable berberine HCl with Chromax® chromium, a patented form of chromium that has been studied in human clinical trials.
Berberine is the foundation of the formula, while Chromax® adds targeted chromium support. Together, they’re included to support healthy blood sugar, cholesterol levels, metabolism, hormone balance, and weight management.*
We also formulated Berberine+ without:
-
Dairy
-
Gluten
-
GMOs
-
Synthetic dyes
-
Fillers
-
PEG
-
Artificial preservatives
-
Toxic heavy metals
We recommend taking one capsule twice daily, ideally 15–30 minutes before meals. If you’re taking prescription medication, particularly medication that affects blood glucose or cholesterol, talk with your healthcare professional before starting Berberine+.
The research on berberine and cholesterol is encouraging, but supplementation works best when considered alongside the broader picture of cardiovascular and metabolic health.
Talk With Your Healthcare Provider Before Adding Berberine
Berberine is being studied as a way to support healthier lipid levels, but the evidence is still developing. If you’re considering it specifically for cholesterol, discuss how it fits with your current diet, lifestyle, medications, and cardiovascular care with your healthcare professional.
Ready to explore metabolic support? Discover Berberine+, our berberine HCl and Chromax® chromium formula designed for adults looking to support their metabolism.*
Not sure which formula fits your needs? Take our 60-second Build Your Biology Plan quiz to discover products that may support your health priorities.
FAQs
Does berberine lower LDL cholesterol?
Research suggests berberine may reduce LDL cholesterol. Clinical studies and systematic reviews have reported improvements in LDL among people taking berberine, although the size of the effect varies between studies.
Does berberine lower triglycerides?
Yes, triglycerides have also decreased in clinical studies of berberine. The extent of the reduction varies depending on factors such as the participants, dose, treatment duration, and study design.
Can you take berberine with cholesterol medication?
Talk with your healthcare professional before combining berberine with cholesterol medication. Your clinician can review your medications, health history, and potential interactions and advise whether adding a berberine supplement is appropriate for you.
